Placeholder product photography for this preview build — final vial imagery and label artwork to be supplied by the client.
Tirzepatide
10 mg · Lyophilized powder · SKU WV-TIRZ-10
A 39-residue dual agonist at the GIP and GLP-1 receptors, with the balance tilted toward GIP.
Compound information
Tirzepatide activates two incretin receptors from one molecule, and the ratio matters: its affinity is weighted toward GIP rather than being evenly split. That imbalance is the experimental interest, because GIP and GLP-1 signalling produce different effects on insulin secretion and adipose tissue, and separating their contributions requires comparison against single agonists.
Research context
- GIP and GLP-1 receptor binding ratio and biased signalling
- Insulin and glucagon secretion under glucose challenge
- Adipose tissue GIP receptor activity
- Comparative work against selective GLP-1 agonists
Reconstitution & handling
Allow the vial to reach room temperature before opening. Reconstitute with bacteriostatic water introduced slowly against the vial wall — do not inject directly onto the lyophilized cake and do not shake.
- Store lyophilized at −20 °C, protected from light.
- Store reconstituted solution at 2–8 °C and use within the study window.
- Avoid repeated freeze–thaw cycles.
- Handle under standard laboratory practice with appropriate PPE.
Shipping & documentation
Orders are dispatched same-day when placed before 14:00 local time. Compounds ship lyophilized and are shelf-stable in transit; packaging is discreet and tamper-evident with tracking on every order.
A lot-specific Certificate of Analysis is issued for every batch and is available from the lab results library.